Drug
Ctx310
Ctx310: highest development phase Phase 1, developed by CRISPR Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- CRISPR Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CTX310 NCT07491172 | Phase 1 | Cardiovascular |
Latest
No recent events.
Follow Ctx310 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.